Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts

Amer M. Zeidan; Uwe Platzbecker; Guillermo Garcia-Manero; Mikkael A. Sekeres; Pierre Fenaux; Amy E. DeZern; Peter L. Greenberg; Michael R. Savona; Joseph G. Jurcic; Amit K. Verma; Ghulam J. Mufti; Rena Buckstein; Valeria Santini; Jeevan K. Shetty; Rodrigo Ito; Jennie Zhang; George Zhang; Xianwei Ha; Jay T. Backstrom; Rami S. Komrokji

doi:10.1182/blood.2022016171

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts

Amer M. Zeidan, Uwe Platzbecker, Guillermo Garcia-Manero, Mikkael A. Sekeres, Pierre Fenaux, Amy E. DeZern, Peter L. Greenberg, Michael R. Savona, Joseph G. Jurcic, Amit K. Verma, Ghulam J. Mufti, Rena Buckstein, Valeria Santini, Jeevan K. Shetty, Rodrigo Ito, Jennie Zhang, George Zhang, Xianwei Ha, Jay T. Backstrom, Rami S. Komrokji

Oncology

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	2170-2174
Number of pages	5
Journal	Blood
Volume	140
Issue number	20
DOIs	https://doi.org/10.1182/blood.2022016171
State	Published - Nov 17 2022

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2022016171

Cite this

Zeidan, A. M., Platzbecker, U., Garcia-Manero, G., Sekeres, M. A., Fenaux, P., DeZern, A. E., Greenberg, P. L., Savona, M. R., Jurcic, J. G., Verma, A. K., Mufti, G. J., Buckstein, R., Santini, V., Shetty, J. K., Ito, R., Zhang, J., Zhang, G., Ha, X., Backstrom, J. T., & Komrokji, R. S. (2022). Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts. Blood, 140(20), 2170-2174. https://doi.org/10.1182/blood.2022016171

Zeidan, AM, Platzbecker, U, Garcia-Manero, G, Sekeres, MA, Fenaux, P, DeZern, AE, Greenberg, PL, Savona, MR, Jurcic, JG, Verma, AK, Mufti, GJ, Buckstein, R, Santini, V, Shetty, JK, Ito, R, Zhang, J, Zhang, G, Ha, X, Backstrom, JT & Komrokji, RS 2022, 'Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts', Blood, vol. 140, no. 20, pp. 2170-2174. https://doi.org/10.1182/blood.2022016171

@article{4308f0e796a145fd975b09d0c93cef02,

title = "Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts",

author = "Zeidan, {Amer M.} and Uwe Platzbecker and Guillermo Garcia-Manero and Sekeres, {Mikkael A.} and Pierre Fenaux and DeZern, {Amy E.} and Greenberg, {Peter L.} and Savona, {Michael R.} and Jurcic, {Joseph G.} and Verma, {Amit K.} and Mufti, {Ghulam J.} and Rena Buckstein and Valeria Santini and Shetty, {Jeevan K.} and Rodrigo Ito and Jennie Zhang and George Zhang and Xianwei Ha and Backstrom, {Jay T.} and Komrokji, {Rami S.}",

note = "Funding Information: This study was supported by Celgene , a Bristol-Myers Squibb Company , in collaboration with Acceleron Pharma Inc, a subsidiary of Merck & Co, Inc, Rahway, NJ, USA and by Bloodwise UK grants 10024 and 14017 (G.J.M.) and Cancer Research UK grant A22324 (G.J.M.). ",

year = "2022",

month = nov,

day = "17",

doi = "10.1182/blood.2022016171",

language = "English (US)",

volume = "140",

pages = "2170--2174",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "20",

}

TY - JOUR

T1 - Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts

AU - Zeidan, Amer M.

AU - Platzbecker, Uwe

AU - Garcia-Manero, Guillermo

AU - Sekeres, Mikkael A.

AU - Fenaux, Pierre

AU - DeZern, Amy E.

AU - Greenberg, Peter L.

AU - Savona, Michael R.

AU - Jurcic, Joseph G.

AU - Verma, Amit K.

AU - Mufti, Ghulam J.

AU - Buckstein, Rena

AU - Santini, Valeria

AU - Shetty, Jeevan K.

AU - Ito, Rodrigo

AU - Zhang, Jennie

AU - Zhang, George

AU - Ha, Xianwei

AU - Backstrom, Jay T.

AU - Komrokji, Rami S.

N1 - Funding Information: This study was supported by Celgene , a Bristol-Myers Squibb Company , in collaboration with Acceleron Pharma Inc, a subsidiary of Merck & Co, Inc, Rahway, NJ, USA and by Bloodwise UK grants 10024 and 14017 (G.J.M.) and Cancer Research UK grant A22324 (G.J.M.).

PY - 2022/11/17

Y1 - 2022/11/17

UR - http://www.scopus.com/inward/record.url?scp=85141474820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85141474820&partnerID=8YFLogxK

U2 - 10.1182/blood.2022016171

DO - 10.1182/blood.2022016171

M3 - Article

C2 - 35797468

AN - SCOPUS:85141474820

SN - 0006-4971

VL - 140

SP - 2170

EP - 2174

JO - Blood

JF - Blood

IS - 20

ER -

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this